title: Subclinical venous access infection and clinical worsening in pulmonary arterial hypertension.
authors.affiliation: Hospices Civils de Lyon, Hôpital Louis Pradel, National Reference Center for Rare Pulmonary Diseases, Competence Center for Severe Pulmonary Hypertension, Lyon, France.
authors.forename: Nader
authors.initials: N
authors.lastname: Chebib
authors.affiliation: Hospices Civils de Lyon, Hôpital Louis Pradel, National Reference Center for Rare Pulmonary Diseases, Competence Center for Severe Pulmonary Hypertension, Lyon, France; Claude Bernard Lyon 1 University, University of Lyon, INRA, UMR754, Lyon, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Mornex
authors.affiliation: Hospices Civils de Lyon, Hôpital Louis Pradel, National Reference Center for Rare Pulmonary Diseases, Competence Center for Severe Pulmonary Hypertension, Lyon, France; Claude Bernard Lyon 1 University, University of Lyon, INRA, UMR754, Lyon, France.
authors.forename: Vincent
authors.initials: V
authors.lastname: Cottin
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage; D055499:Catheter-Related Infections / Q000209:etiology*; D062905:Central Venous Catheters / Q000009:adverse effects*; D011464:Epoprostenol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011669:Pulmonary Wedge Pressure / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D011464:Epoprostenol